Man Group
OLMA icon

Man Group’s Olema Pharmaceuticals OLMA Stock Holding History

Man Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Hold
0
– – – 1928
2021
Q4 		– Sell
-14,500
Closed -$400K – 2061
2021
Q3 		$400K Buy
+14,500
New +$391K ﹤0.01% 1587

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Man Group's OLMA Position: Q1 2023 in Review

Man Group held its Olema Pharmaceuticals (OLMA) position steady in Q1 2023 at 0 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1928.

Man Group first reported a position in OLMA in Q3 2021 and has held it in 1 quarter since. The position peaked at $400K in Q3 2021. 65 funds tracked by Wall St. Rank hold OLMA as of Q1 2023.

  • Man Group held 0 shares of Olema Pharmaceuticals worth $124K as of Q1 2023.
  • Man Group left its Olema Pharmaceuticals share count unchanged in Q1 2023.
  • Olema Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q1 2023, its #1928 holding.
  • Man Group first reported a position in Olema Pharmaceuticals in Q3 2021 and has held it in 1 quarter since.
  • Man Group's Olema Pharmaceuticals position peaked at $400K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2023.

Based on Man Group's 13F filing for Q1 2023, filed 15 May 2023.